Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News PAVmed Inc PAVMZ


Primary Symbol: PAVM

Healthcare Medical Devices
PAVmed Inc. is a multi-product, commercial-stage medical technology company. The Company operates through three lines of business: Medical Devices, Diagnostics, and Digital Health. Its subsidiary includes Lucid Diagnostics Inc., which is a commercial-stage cancer prevention medical diagnostics company that markets the EsoGuard Esophageal DNA Test and EsoCheck Esophageal Cell Collection Device... see more

Recent & Breaking News (NDAQ:PAVM)

PAVmed Announces Filing of Registration Statement Relating to Private Placement

Business Wire March 28, 2017

PAVmed Names Medical Device Industry Veteran Dennis M. McGrath as Chief Financial Officer

Business Wire March 21, 2017

PAVmed Announces Closing of Additional Financing

Business Wire March 9, 2017

PAVmed Announces Exchange Offer

Business Wire February 23, 2017

PAVmed to Hold Business Update Conference Call and Webcast on February 22nd

Business Wire February 17, 2017

PAVmed Announces Warrants Now Exercisable for Cash

Business Wire February 3, 2017

PAVmed Inc. Announces Closing of Financing

Business Wire February 2, 2017

15 Biggest Mid-Day Gainers For Tuesday

Benzinga.com  January 31, 2017

12 Biggest Mid-Day Losers For Friday

Benzinga.com  December 23, 2016

PAVmed Files 510(k) FDA Submission for PortIO™ Intraosseous Infusion System

Business Wire December 19, 2016

PAVmed to Hold Business Update Conference Call and Webcast on December 7th

Business Wire December 2, 2016

Stocks Hitting 52-Week Lows

Benzinga.com  November 15, 2016

PAVmed to Present at the Canaccord Genuity Medical Technologies & Diagnostics Forum

Business Wire November 10, 2016

PAVmed Partners with Leading Academic Institutions to Develop Revolutionary Ear Device

Business Wire November 4, 2016

PAVmed Files Registration Statement for Issuance of Shares Underlying IPO Warrants

Business Wire October 28, 2016

PAVmed to Present at the Ladenburg Thalmann 2016 Healthcare Conference

Business Wire September 20, 2016

PAVmed to Present at the Rodman & Renshaw 18th Annual Global Investment Conference

Business Wire September 7, 2016

PAVmed Announces Initiation of Research Coverage by The Benchmark Company

Business Wire July 26, 2016

PAVmed Units to Separate into Common Stock and Warrants on July 27

Business Wire July 26, 2016

PAVmed Sets Q4 2016 Timeline for FDA Submission of Its First Product

Business Wire July 14, 2016